Table of Contents
The Brown University Psychopharmacology Update · 2007
DOI: 10.1002/pu.20035 ↗Abstract
Abstract CUtLASS 1 Findings – No Clinical Advantage Between 1st‐ and 2nd‐Generation Antipsychotics Insomnia Medication Ramelteon Shows No Potential for Abuse or Adverse Effects Aripiprazole and Lithium: Neuroleptic Malignant Syndrome Divalproex ER for Acute Mania CUtLASS 1 Author Commentary Lamotrigine vs. Citalopram for Bipolar Depression Atomoxetine for Hyperactivity in Autism Modafinil and Unconstrained Motor Activity in Schizophrenia Hair Loss with Lamotrigine Label Revision: Overdosage Risk with Venlafaxine Approval: Quetiapine for Bipolar Depression
EUVIMED